Jiangsu Hengrui Medicine Co., Ltd. mainly produces anti-tumor drugs, anti-infectious drugs, antibiotic drugs and drugs for operation, and the first kind generates most of the company's profit. In the consecutive seven years since it went public, the profit of main business has been increasing by 28.7% year-on-year, and the net profit has been enjoying a CAGR of 22%. In addition, the company successively purchased Chengdu Hengrui Pharmaceutical Co., Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd., and the latter became a new drug R&D center afterward.
The two R&D centers of the company are respectively located in Lianyungang and Shanghai, both having its own work division and pipelining production ability. Shanghai R&D center is mainly in charge of the prophase research of new drugs.
In the year of 2006, the company's sales revenue from anti-tumor drugs reached RMB 856 million, up 632% from a year earlier. New drugs were successively launched into the market and thus the era of oxaliplatin and docetaxel came up. The sales revenue of Narcotic analgesic drugs mainly including Levobupivacaine and Atracurium Besilate amounted to RMB 128 million, rising 472% year-on-year. And anti-infectious drugs mainly including clarithromycin realized sales revenue of RMB 247 million, a rise of 193% over 2005.
In the years of 2004-2006, the capital invested into R&D was RMB 80 million, 100 million and 120 million respectively, accounting for 7.01%, 8.48% and 8.43% of the annual revenue from main business separately. Five kinds of the company's new drugs are in clinic trial or in planned clinic trial currently.
It is forecasted that in the year of 2007, the sales revenue of Jiangsu Hengrui Medicine Co., Ltd. will reach RMB 1.71 billion from the main business, up by 20% year-on-year; the net profit will amount to RMB 301 million, up 45.4% from a year earlier. In 2008, the sales revenue from main business and the net profit will be RMB 2.03 billion and RMB 450 million respectively with a year-on-year growth of 18.7% and 49.5% separately.
Structure of Main Business of Hengrui Medicine Co., Ltd
Historical Statistics of the Hengrui's Operation (Unit: RMB Million)
|
